Paenidigyamycin A, potent antiparasitic imidazole alkaloid from the ghanaian Paenibacillus sp. De2Sh

MakaleAçık ErişimScopus SJRQ2
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

A new alkaloid paenidigyamycin A (1) was obtained from the novel Ghanaian Paenibacillus sp. isolated from the mangrove rhizosphere soils of the Pterocarpus santalinoides tree growing in the wetlands of the Digya National Park, Ghana. Compound 1 was isolated on HPLC at tR = 37.0 min and its structure determined by MS, 1D, and 2D-NMR data. When tested against L. major, 1 (IC50 0.75 µM) was just as effective as amphotericin B (IC50 0.31 µM). Against L. donovani, 1 (IC50 7.02 µM) was twenty-two times less active than amphotericin B (IC50 0.32 µM), reinforcing the unique effectiveness of 1 against L. major. For T. brucei brucei, 1 (IC50 0.78 µM) was ten times more active than the laboratory standard Coptis japonica (IC50 8.20 µM). The IC50 of 9.08 µM for 1 against P. falciparum 3d7 compared to artesunate (IC50 36 nM) was not strong, but this result suggests the possibility of using the paenidigyamycin scaffold for the development of potent antimalarial drugs. Against cercariae, 1 showed high anticercaricidal activity compared to artesunate. The minimal lethal concentration (MLC) and minimal effective concentration (MEC) of the compound were 25 and 6.25 µM, respectively, while artesunate was needed in higher quantities to produce such results. However, 1 (IC50 > 100 µM) was not active against T. mobilensis.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/munzur/3267Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3390/md17010009Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
32
OpenAlex
32
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorOsei, Enoch
dc.contributor.authorKwain, Samuel
dc.contributor.authorMawuli, Gilbert Tetevi
dc.contributor.authorAnang, Abraham Kwabena
dc.contributor.authorOwusu, Kofi Baffour-Awuah
dc.contributor.authorCamas, Mustafa
dc.contributor.authorCamas, Anil Sazak
dc.contributor.authorOhashi, Mitsuko
dc.contributor.authorAlexandru-Crivac, Cristina-Nicoleta
dc.contributor.authorDeng, Hai
dc.contributor.authorJaspars, Marcel
dc.contributor.authorKyeremeh, Kwaku
dc.date.accessioned2026-10-28T14:56:24.813081768Z
dc.date.available2026-10-28T14:56:24.813081768Z
dc.date.issued2019
dc.description.abstractA new alkaloid paenidigyamycin A (1) was obtained from the novel Ghanaian Paenibacillus sp. isolated from the mangrove rhizosphere soils of the Pterocarpus santalinoides tree growing in the wetlands of the Digya National Park, Ghana. Compound 1 was isolated on HPLC at tR = 37.0 min and its structure determined by MS, 1D, and 2D-NMR data. When tested against L. major, 1 (IC50 0.75 µM) was just as effective as amphotericin B (IC50 0.31 µM). Against L. donovani, 1 (IC50 7.02 µM) was twenty-two times less active than amphotericin B (IC50 0.32 µM), reinforcing the unique effectiveness of 1 against L. major. For T. brucei brucei, 1 (IC50 0.78 µM) was ten times more active than the laboratory standard Coptis japonica (IC50 8.20 µM). The IC50 of 9.08 µM for 1 against P. falciparum 3d7 compared to artesunate (IC50 36 nM) was not strong, but this result suggests the possibility of using the paenidigyamycin scaffold for the development of potent antimalarial drugs. Against cercariae, 1 showed high anticercaricidal activity compared to artesunate. The minimal lethal concentration (MLC) and minimal effective concentration (MEC) of the compound were 25 and 6.25 µM, respectively, while artesunate was needed in higher quantities to produce such results. However, 1 (IC50 > 100 µM) was not active against T. mobilensis.
dc.description.sponsorshipCenter for African Studies, CAS
dc.description.sponsorshipWest African Research Association, Boston University, WARA
dc.description.sponsorshipDepartment of Biochemistry, University of Cambridge
dc.description.sponsorshipMedical Research Council, MRC
dc.description.sponsorshipCambridge-MIT Institute, CMI
dc.description.sponsorshipDepartment of Chemistry, Aligarh Muslim University
dc.description.sponsorshipCambridge-Africa Partnership for Research Excellence
dc.description.sponsorshipCarnegie Foundation for the Advancement of Teaching
dc.description.sponsorshipUniversity of Ghana, UG
dc.description.sponsorshipThird World Academy of Sciences, TWAS
dc.description.sponsorshipNew Partnership for Africa's Development, NEPAD
dc.description.sponsorshipCarnegie Corporation of New York, CCNY
dc.description.sponsorship, (MR/S00520X/1)
dc.description.sponsorshipThe World Academy of Sciences, TWAS, (Award_17-512 RG/CHE/AF/AC_G)
dc.description.sponsorshipThe World Academy of Sciences, TWAS
dc.identifier.articlenumber9
dc.identifier.doi10.3390/md17010009
dc.identifier.eissn1660-3397
dc.identifier.issn1660-3397
dc.identifier.issue1
dc.identifier.pmcidPMC6356793
dc.identifier.pmid30586918
dc.identifier.scopus2-s2.0-85059228370
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/munzur/3267
dc.identifier.volume17
dc.identifier.wosWOS:000458053200009
dc.language.isoen
dc.publisherMDPI AG
dc.relation.ispartofMarine Drugs
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectLeishmania
dc.subjectPaenidigyamycin
dc.subjectPlasmodium
dc.subjectSchistosome
dc.subjectTrichomonas
dc.subjectTrypanosome
dc.subject.otherAlkaloids
dc.subject.otherAmphotericin B
dc.subject.otherAnimals
dc.subject.otherAntiparasitic Agents
dc.subject.otherArtesunate
dc.subject.otherCercaria
dc.subject.otherDrug Evaluation, Preclinical
dc.subject.otherGhana
dc.subject.otherImidazoles
dc.subject.otherInhibitory Concentration 50
dc.subject.otherLeishmania donovani
dc.subject.otherPaenibacillus
dc.subject.otherParasitic Diseases
dc.subject.otherPlasmodium falciparum
dc.subject.otherPterocarpus
dc.subject.otherRhizosphere
dc.subject.otherSoil Microbiology
dc.subject.otherTrypanosoma brucei brucei
dc.subject.otherWetlands
dc.subject.otherampicillin
dc.subject.otherantiinfective agent
dc.subject.otherantiparasitic agent
dc.subject.othermetronidazole
dc.subject.otherpaenidigyamycin a
dc.subject.otherunclassified drug
dc.subject.otheralkaloid
dc.subject.otherimidazole derivative
dc.subject.otherantibacterial activity
dc.subject.otherArticle
dc.subject.otherbacterial strain
dc.subject.otherbiological activity
dc.subject.othercontrolled study
dc.subject.otherCoptis
dc.subject.otherCoptis japonica
dc.subject.otherdrug potency
dc.subject.otherdrug structure
dc.subject.otherhigh performance liquid chromatography
dc.subject.otherIC50
dc.subject.otherLeishmania major
dc.subject.otherminimum effective concentration
dc.subject.otherminimum lethal concentration
dc.subject.othernonhuman
dc.subject.otheranimal
dc.subject.otherchemistry
dc.subject.otherdrug effect
dc.subject.otherisolation and purification
dc.subject.othermicrobiology
dc.subject.otherparasitosis
dc.subject.otherpreclinical study
dc.subject.otherwetland
dc.titlePaenidigyamycin A, potent antiparasitic imidazole alkaloid from the ghanaian Paenibacillus sp. De2Sh
dc.typeArticle
rdl.citation.openalex32
rdl.citation.scopus32
rdl.departmentMarine and Plant Research Laboratory of Ghana, Department of Chemistry, School of Physical and Mathematical Sciences, University of Ghana, P.O. Box LG 56, Legon-Accra, Ghana
rdl.departmentDepartment of Parasitology, Noguchi Memorial Institute for Medical Research, University of Ghana, P.O. Box LG 581, Legon-Accra, Ghana
rdl.departmentDepartment of Bioengineering, Munzur University, 62000 Tunceli, Turkey
rdl.departmentSection of Environmental Parasitology, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
rdl.departmentMarine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Old Aberdeen, AB24 3UE Scotland, UK
rdl.oa.statusgold
rdl.oa.statusclosed
rdl.oa.statusgreen
rdl.oa.urlhttps://www.mdpi.com/1660-3397/17/1/9/pdf?version=1545648671
rdl.scopus.quartileQ2
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED